Patents by Inventor Michael T. Kelly

Michael T. Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080236032
    Abstract: Hydrogen storage fuel compositions and devices comprising a mixture of at least one chemical hydride compound and at least one proton source, and methods for thermally initiated hydrogen generation from fuel compositions are disclosed. The fuel compositions comprise an excess of hydridic hydrogens relative to protic hydrogens. Fuel cartridges suitable for use with compositions which generate hydrogen upon the application of thermal initiation and methods for operating the fuel cartridges are also disclosed.
    Type: Application
    Filed: August 23, 2007
    Publication date: October 2, 2008
    Inventors: Michael T. Kelly, Jeffrey V. Ortega
  • Publication number: 20080172932
    Abstract: Hydrogen storage fuel compositions comprising a mixture of at least one chemical hydride compound and at least one compound, polymer, carboxylic acid or salt that acts as a water surrogate source, and methods for thermally initiated hydrogen generation from fuel compositions, are disclosed. The water surrogate source/chemical hydride compositions are preferably solids, and may be powders, caplets, tablets, pellets or granules, for example. The water surrogate source/chemical hydride compositions may comprise alternating layers of the chemical hydride and of the water surrogate source.
    Type: Application
    Filed: November 29, 2007
    Publication date: July 24, 2008
    Inventors: Michael T. Kelly, Kevin W. McNamara, Xiaolei Sun, Alexander MacLachan
  • Patent number: 7323148
    Abstract: A hydrogen generator capable of operating in any orientation and having no moving parts includes a catalyst retaining structure. The catalyst retaining structure is disposed in a housing and serves to separate the housing into a fuel holding portion and a hydrogen chamber. The catalyst retaining structure also includes one or more pores, each pore being in communication with the fuel holding and hydrogen chambers. A catalyst, that promotes the generation of hydrogen gas upon contact with the fuel, is disposed within the pores. The fuel enters the pores and thereupon generates hydrogen gas which passes into the hydrogen chamber. Contact of the fuel with the catalyst in the pores may be controlled and the position of the fuel-hydrogen interface within the pore may be moved so as to regulate the generation of hydrogen. The catalyst retaining structure can take different forms, including one or more hollow elongated members or plates, and may further incorporate hydrophobic and/or hydrophilic membranes.
    Type: Grant
    Filed: November 5, 2003
    Date of Patent: January 29, 2008
    Assignee: Millennium Cell, Inc.
    Inventors: Shailesh A. Shah, Michael T. Kelly
  • Patent number: 7220290
    Abstract: The present invention relates to a composition and method for storage and controlled release of hydrogen. In particular, the present invention relates to the use of borohydride based solutions as a hydrogen storage source and a catalyst system to release hydrogen therefrom.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: May 22, 2007
    Assignee: Millennium Cell, Inc.
    Inventors: Steven C. Amendola, Michael Binder, Stefanie L. Sharp-Goldman, Michael T. Kelly, Phillip J. Petillo
  • Patent number: 7214439
    Abstract: The present invention relates to the use of triborohydride salts as hydrogen storage materials. The present invention also relates to a system of using triborohydride salts to generate hydrogen gas for use in a fuel cell or other hydrogen-consuming device. A novel method of preparing triborohydride salts is also disclosed, wherein gaseous diborane is reacted with a carbonate suspended in a non-aqueous solvent in a suitable vessel with agitation. The process is typically carried out utilizing sodium carbonate to form sodium triborohydride. Other triborohydride salts can then be formed by cationic exchange. Hydrogen generating fuels according to the present invention include aqueous or hydroalcoholic solutions or slurries of a triborohydride salt, which may additionally contain a borohydride salt to provide operation over a broader temperature range.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: May 8, 2007
    Assignee: Millennium Cell, Inc.
    Inventors: Jeffrey V. Ortega, Michael T. Kelly, Jonathan L. Snover, Jason C. Brady, Ying Wu
  • Patent number: 7153826
    Abstract: Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: December 26, 2006
    Assignee: Seatek Marine Biotechnology, Inc.
    Inventor: Michael T. Kelly
  • Patent number: 7019105
    Abstract: The present invention relates to compositions and processes for producing borohydride compounds. In particular, the present invention provides efficient processes and compositions for the large-scale production of borohydride compounds.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: March 28, 2006
    Assignee: Millennium Cell, Inc.
    Inventors: Steven C. Amendola, Michael T. Kelly
  • Publication number: 20040191152
    Abstract: The present invention relates to compositions and processes for producing borohydride compounds. In particular, the present invention provides efficient processes and compositions for the large-scale production of borohydride compounds.
    Type: Application
    Filed: April 4, 2002
    Publication date: September 30, 2004
    Inventors: Steven C. Amendola, Michael T. Kelly
  • Patent number: 6790829
    Abstract: Several cyclic decapeptides having antibiotic activity are disclosed. The decapeptides are active against both gram positive and gram negative bacteria.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: September 14, 2004
    Assignees: SeaTek Marine Biotechnology, Inc., University of British Columbia
    Inventors: Michael T. Kelly, Raymond J. Andersen, Jeff Gerard
  • Patent number: 6784283
    Abstract: N- and C-modified linear cationic peptides having antibiotic activity are disclosed, which peptides are particularly active against gram positive bacteria.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: August 31, 2004
    Assignees: The University of British Columbia, Ocean Pharmaceuticals, Inc.
    Inventors: Raymond J. Andersen, Michael T. Kelly, Todd A. Barsby
  • Publication number: 20040120889
    Abstract: A hydrogen generator capable of operating in any orientation and having no moving parts includes a catalyst retaining structure. The catalyst retaining structure is disposed in a housing and serves to separate the housing into a fuel holding portion and a hydrogen chamber. The catalyst retaining structure also includes one or more pores, each pore being in communication with the fuel holding and hydrogen chambers. A catalyst, that promotes the generation of hydrogen gas upon contact with the fuel, is disposed within the pores. The fuel enters the pores and thereupon generates hydrogen gas which passes into the hydrogen chamber. Contact of the fuel with the catalyst in the pores may be controlled and the position of the fuel-hydrogen interface within the pore may be moved so as to regulate the generation of hydrogen. The catalyst retaining structure can take different forms, including one or more hollow elongated members or plates, and may further incorporate hydrophobic and/or hydrophilic membranes.
    Type: Application
    Filed: November 5, 2003
    Publication date: June 24, 2004
    Inventors: Shailesh A. Shah, Michael T. Kelly
  • Publication number: 20040033194
    Abstract: The present invention relates to a composition and method for storage and controlled release of hydrogen. In particular, the present invention relates to the use of borohydride based solutions as a hydrogen storage source and a catalyst system to release hydrogen therefrom.
    Type: Application
    Filed: August 11, 2003
    Publication date: February 19, 2004
    Inventors: Steven C. Amendola, Michael Binder, Stefanie L. Sharp-Goldman, Michael T. Kelly, Phillip J. Petillo
  • Publication number: 20040023857
    Abstract: Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.
    Type: Application
    Filed: December 30, 2002
    Publication date: February 5, 2004
    Inventor: Michael T Kelly
  • Patent number: 6683025
    Abstract: The present invention relates to a composition and method for storage and controlled release of hydrogen. In particular, the present invention relates to the use of borohydride based solutions as a hydrogen storage source and a catalyst system to release hydrogen therefrom.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: January 27, 2004
    Assignee: Millennium Cell, Inc.
    Inventors: Steven C. Amendola, Michael Binder, Stefanie L. Sharp-Goldman, Michael T. Kelly, Phillip J. Petillo
  • Patent number: 6670444
    Abstract: The present invention relates to processes for producing borohydride compounds. In particular, the present invention provides efficient processes and compositions for the large-scale production of borohydride compounds of the formula YBH4 by the reaction of a boron-containing compound represented by the formula BX3 with hydrogen or an aldehyde to obtain diborane and HX, and reacting the diborane with a Y-containing base selected from those represented by the formula Y2O, YOH and Y2CO3 to obtain YBH4 and YBO2. Y is selected from the group consisting of the alkali metals, pseudo-alkali metals, alkaline earth metals, an ammonium ion, and quaternary amines of the formula NR4+, wherein each R is independently selected from hydrogen and a straight- or branched-chain C1-4 alkyl group, and X is selected from the group consisting of halide ions, —OH, —R′ and —OR′ groups, chalcogens, and chalcogenides, wherein R′ is a straight- or branched-chain C1-4 alkyl group.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: December 30, 2003
    Assignee: Millennium Cell, Inc.
    Inventors: Steven C. Amendola, Michael T. Kelly, Jeffrey V. Ortega, Ying Wu
  • Patent number: 6586563
    Abstract: Processes for synthesizing borohydride compounds with reduced energy requirements and high efficiency are disclosed. The processes include the reaction of a base with a borane complex or diborane to produce a borohydride compound of formula YBH4, where Y is a monovalent cationic moiety.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: July 1, 2003
    Assignee: Millennium Cell, Inc.
    Inventors: Jeffrey V. Ortega, Ying Wu, Steven C. Amendola, Michael T. Kelly
  • Publication number: 20030114632
    Abstract: Processes for synthesizing borohydride compounds with reduced energy requirements and high efficiency are disclosed. The processes include the reaction of a base with a borane complex or diborane to produce a borohydride compound of formula YBH4, where Y is a monovalent cationic moiety.
    Type: Application
    Filed: December 18, 2001
    Publication date: June 19, 2003
    Inventors: Jeffrey V. Ortega, Ying Wu, Steven C. Amendola, Michael T. Kelly
  • Publication number: 20030092877
    Abstract: The present invention relates to processes for producing borohydride compounds. In particular, the present invention provides efficient processes and compositions for the large-scale production of borohydride compounds of the formula YBH4 by the reaction of a boron-containing compound represented by the formula BX3 with hydrogen or an aldehyde to obtain diborane and HX, and reacting the diborane with a Y-containing base selected from those represented by the formula Y2O, YOH and Y2CO3 to obtain YBH4 and YBO2. Y is selected from the group consisting of the alkali metals, pseudo-alkali metals, alkaline earth metals, an ammonium ion, and quaternary amines of the formula NR4+, wherein each R is independently selected from hydrogen and a straight- or branched-chain C1-4 alkyl group, and X is selected from the group consisting of halide ions, —OH, —R′ and —OR′ groups, chalcogens, and chalcogenides, wherein R′ is a straight- or branched-chain C1-4 alkyl group.
    Type: Application
    Filed: December 27, 2002
    Publication date: May 15, 2003
    Inventors: Steven C. Amendola, Michael T. Kelly, Jeffrey V. Ortega, Ying Wu
  • Patent number: 6534033
    Abstract: The present invention relates to a composition and method for storage and controlled release of hydrogen. In particular, the present invention relates to the use of borohydride based solutions as a hydrogen storage source and a catalyst system to release hydrogen therefrom.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: March 18, 2003
    Assignee: Millennium Cell, Inc.
    Inventors: Steven C. Amendola, Michael Binder, Stefanie L. Sharp-Goldman, Michael T. Kelly, Phillip J. Petillo
  • Patent number: 6524542
    Abstract: Processes for synthesizing borohydride compounds with reduced energy requirements are disclosed.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: February 25, 2003
    Assignee: Millennium Cell, Inc.
    Inventors: Steven C. Amendola, Michael T. Kelly, Ying Wu